| [1] |
Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia[J]. J Cachexia Sarcopenia Muscle, 2016, 7(5):512-514.
|
| [2] |
中国国家医疗保障局.国家医保信息业务编码标准数据库动态维护[EB/OL].[2024-4-17].
URL
|
| [3] |
Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle, 2022, 13(1):86-99.
|
| [4] |
刘娟，丁清清，周白瑜,等.中国老年人肌少症诊疗专家共识（2021）[J].中华老年医学杂志，2021,40(8):943-952.
|
| [5] |
Wang Y, Zhang Y, Lane NE, et al. Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study[J]. J Cachexia Sarcopenia Muscle, 2022, 13(5): 2340-2351.
|
| [6] |
Han P, Zhao J, Guo Q, et al. Incidence, risk factors, and the protective effect of high body mass index against sarcopenia in suburb-dwelling elderly Chinese populations[J]. J Nutr Health Aging, 2016, 20(10):1056-1060.
|
| [7] |
Yu R, Wong M, Leung J, et al. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults[J]. Geriatr Gerontol Int, 2014, 14 Suppl 1:15-28.
|
| [8] |
Nakakubo S, Doi T, Tsutsumimoto K, et al. Sleep duration and progression to sarcopenia in Japanese community-dwelling older adults: A 4 year longitudinal study[J]. J Cachexia Sarcopenia Muscle, 2021, 12(4):1034-1041.
|
| [9] |
Zhang Y, Chen X, Hou L, et al. Prevalence and risk factors governing the loss of muscle function in elderly sarcopenia patients: A longitudinal study in China with 4 years of follow-up[J]. J Nutr Health Aging, 2020, 24(5):518-524.
|
| [10] |
Dodds RM, Granic A, Davies K, et al. Prevalence and incidence of sarcopenia in the very old: Findings from the Newcastle 85+Study[J]. J Cachexia Sarcopenia Muscle, 2017, 8(2):229-237.
|
| [11] |
Trevisan C, Vetrano DL, Calvani R, et al. Twelve-year sarcopenia trajectories in older adults: Results from a population-based study[J]. J Cachexia Sarcopenia Muscle, 2022, 13(1):254-263.
|
| [12] |
Locquet M, Bruyère O, Lengelé L, et al. Relationship between smoking and the incidence of sarcopenia: the SarcoPhAge cohort[J]. Public Health, 2021, 193:101-108.
|
| [13] |
He Y, Cui W, Fang T, et al. Metabolites of the gut microbiota may serve as precise diagnostic markers for sarcopenia in the elderly[J]. Front Microbiol, 2023, 14:1301805.
|
| [14] |
Sha T, Wang N, Wei J, et al. Genetically predicted levels of serum metabolites and risk of sarcopenia: A mendelian randomization study[J]. Nutrients, 2023, 15(18):3964.
|
| [15] |
Han A, Bokshan SL, Marcaccio SE, et al. Diagnostic criteria and clinical outcomes in sarcopenia research: A literature review[J]. J Clin Med, 2018, 7(4):70.
|
| [16] |
Chen Z, Wang Z, Lohman T, et al. Dual-energy X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women[J]. J Nutr, 2007, 137(12):2775-2780.
|
| [17] |
Lee MM, Jebb SA, Oke J, et al. Reference values for skeletal muscle mass and fat mass measured by bioelectrical impedance in 390 565 UK adults[J]. J Cachexia Sarcopenia Muscle, 2020, 11(2):487-496.
|
| [18] |
Yeh C, Chen Y, Lai L, et al. Bioelectrical impedance analysis in a mathematical model for estimating fat-free mass in multiple segments in elderly males[J]. Int J Gerontol, 2012, 6(4):273-277.
|
| [19] |
吴曼，魏玉虾，余灿清，等.中国10个地区成年人骨骼肌质量和手握力的描述性分析[J].中华流行病学杂志，2019,40(4):376-381.
|
| [20] |
Casey P, Alasmar M, McLaughlin J, et al. The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: A systematic review[J]. J Cachexia Sarcopenia Muscle, 2022, 13(5):2298-2309.
|
| [21] |
Fu H, Wang L, Zhang W, et al. Diagnostic test accuracy of ultrasound for sarcopenia diagnosis: A systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle, 2023, 14(1):57-70.
|
| [22] |
Zanker J, Sim M, Anderson K, et al. Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand[J]. J Cachexia Sarcopenia Muscle, 2023, 14(1):142-156.
|
| [23] |
崔华，王朝晖，吴剑卿，等.老年人肌少症防控干预中国专家共识（2023）[J].中华老年医学杂志，2023,42(2):144-153.
|
| [24] |
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3):300-307.e2.
|
| [25] |
Mathiowetz V. Comparison of Rolyan and Jamar dynamometers for measuring grip strength[J]. Occup Ther Int, 2002, 9(3):201-209.
|
| [26] |
Mathiowetz V, Weber K, Volland G, et al. Reliability and validity of grip and pinch strength evaluations[J]. J Hand Surg Am, 1984, 9(2):222-226.
|
| [27] |
Bohannon RW, Schaubert KL. Test-retest reliability of grip-strength measures obtained over a 12-week interval from community-dwelling elders[J]. J Hand Ther, 2005,18(4):426-427.
|
| [28] |
Kim ES, Kawachi I, Chen Y, et al. Association between purpose in life and objective measures of physical function in older adults[J]. JAMA Psychiatry, 2017, 74(10):1039-1045.
|
| [29] |
Peolsson A, Hedlund R, Oberg B. Intra-and inter-tester reliability and reference values for hand strength[J]. J Rehabil Med, 2001, 33(1):36-41.
|
| [30] |
Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability[J]. JAMA, 1999, 281(6):558-560.
|
| [31] |
Auyeung TW, Arai H, Chen LK, et al. Letter to the editor: Normative data of handgrip strength in 26 344 older adults-a pooled dataset from eight cohorts in Asia[J]. J Nutr Health Aging, 2020, 24(1):125-126.
|
| [32] |
Jiang X, Xu X, Ding L, et al. Preoperative low absolute and relative handgrip strength as predictors of postoperative short-term outcomes: A prospective study based on patients aged 60 years and older with gastric cancer[J]. Eur Geriatr Med, 2023, 14(2):251-262.
|
| [33] |
Tobe A, Tanaka A, Shirai Y, et al. Impact of handgrip strength on clinical outcomes after percutaneous coronary intervention[J]. J Atheroscler Thromb, 2023, 30(9):1115-1122.
|
| [34] |
Zhang XM, Jiao J, Zhu C, et al. Association between low handgrip strength and 90-day mortality among older chinese inpatients: A national multicenter prospective cohort study[J]. Front Nutr, 2021, 8:628628.
|
| [35] |
Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach[J]. Age Ageing, 2011, 40(4):423-429.
|
| [36] |
杨琦琦，孙颖.肌少症筛查工具的研究进展[J].中华老年多器官疾病杂志，2020,19(2):152-156.
|
| [37] |
Lu JL, Ding LY, Xu Q, et al. Screening accuracy of SARC-F for sarcopenia in the elderly: A diagnostic meta-analysis[J]. J Nutr Health Aging, 2021, 25(2):172-182.
|
| [38] |
Voelker SN, Michalopoulos N, Maier AB, et al. Reliability and concurrent validity of the SARC-F and its modified versions: A systematic review and meta-analysis[J]. J Am Med Dir Assoc, 2021, 22(9):1864-1876.e16.
|
| [39] |
Yang M, Hu X, Xie L, et al. Comparing mini sarcopenia risk assessment with SARC-F for screening sarcopenia in community-dwelling older adults[J]. J Am Med Dir Assoc, 2019, 20(1):53-57.
|
| [40] |
Rossi AP, Caliari C, Urbani S, et al. Sarcopenia risk evaluation in a sample of hospitalized elderly men and women: Combined use of the Mini Sarcopenia Risk Assessment (MSRA) and the SARC-F[J]. Nutrients, 2021, 13(2):635.
|
| [41] |
Di Vincenzo O, Marra M, Di Gregorio A, et al. Bioelectrical impedance analysis (BIA)-derived phase angle in sarcopenia: A systematic review[J]. Clin Nutr, 2021, 40(5):3052-3061.
|
| [42] |
Chen JL, Chen DM, Luo C, et al. Fibrinogen, fibrin degradation products and risk of sarcopenia[J]. Clin Nutr, 2021, 40(8):4830-4837.
|
| [43] |
Zheng C, Wang E, Li JS, et al. Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer[J]. BMC Geriatr, 2022, 22(1):207.
|
| [44] |
Yin M, Zhang H, Liu Q, et al. Diagnostic performance of clinical laboratory indicators with sarcopenia: Results from the west China health and aging trend study[J]. Front Endocrinol (Lausanne), 2021, 12:785045.
|
| [45] |
Yang J, Zhang T, Feng D, et al. A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer[J]. Colorectal Dis, 2019, 21(5):538-547.
|
| [46] |
Negm AM, Lee J, Hamidian R, et al. Management of sarcopenia: A network meta-analysis of randomized controlled trials[J]. J Am Med Dir Assoc, 2022, 23(5):707-714.
|
| [47] |
Bao W, Sun Y, Zhang T, et al. Exercise programs for muscle mass, muscle strength and physical performance in older adults with sarcopenia: A systematic review and meta-analysis[J]. Aging Dis, 2020, 11(4):863-873.
|
| [48] |
Lu L, Mao L, Feng Y, et al. Effects of different exercise training modes on muscle strength and physical performance in older people with sarcopenia: A systematic review and meta-analysis[J]. BMC Geriatr, 2021, 21(1):708.
|
| [49] |
Shen Y, Shi Q, Nong K, et al. Exercise for sarcopenia in older people: A systematic review and network meta-analysis[J]. J Cachexia Sarcopenia Muscle, 2023, 14(3):1199-1211.
|
| [50] |
Wang H, Huang WY, Zhao Y. Efficacy of exercise on muscle function and physical performance in older adults with sarcopenia: An updated systematic review and meta-analysis[J]. Int J Environ Res Public Health, 2022, 19(13):8212.
|
| [51] |
Chen LK, Lee WJ, Peng LN, et al. Recent advances in sarcopenia research in asia: 2016 update from the Asian Working Group for Sarcopenia[J]. J Am Med Dir Assoc, 2016, 17(8):767.e1-e7.
|
| [52] |
Picorelli AM, Pereira LS, Pereira DS, et al. Adherence to exercise programs for older people is influenced by program characteristics and personal factors: A systematic review[J]. J Physiother, 2014, 60(3):151-156.
|
| [53] |
Wu PY, Huang KS, Chen KM, et al. Exercise, nutrition, and combined exercise and nutrition in older adults with sarcopenia: A systematic review and network meta-analysis[J]. Maturitas, 2021, 145:38-48.
|
| [54] |
Rondanelli M, Klersy C, Terracol G, et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly[J]. Am J Clin Nutr, 2016, 103(3):830-840.
|
| [55] |
吴夕，方悦.强化营养联合抗阻运动对老年肌少症患者的影响[J].临床医药文献电子杂志，2019,6(98):107-108.
|
| [56] |
毛拥军，吴剑卿，刘龚翔，等.老年人营养不良防控干预中国专家共识(2022)[J].中华老年医学杂志，2022,41(7):749-759.
|
| [57] |
Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management[J]. J Nutr Health Aging, 2018, 22(10):1148-1161.
|
| [58] |
Zhu LY, Chan R, Kwok T, et al. Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: A randomized controlled trial[J]. Age Ageing, 2019, 48(2):220-228.
|
| [59] |
Niu K, Liu YL, Yang F, et al. Efficacy of traditional Chinese exercise for sarcopenia: A systematic review and meta-analysis of randomized controlled trials[J]. Front Neurosci, 2022, 16:1094054.
|
| [60] |
Yang M, Hu X, Wang H, et al. Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: A prospective study[J]. J Cachexia Sarcopenia Muscle, 2017, 8(2):251-258.
|
| [61] |
Bai GH, Tsai MC, Tsai HW, et al. Effects of branched-chain amino acid-rich supplementation on EWGSOP2 criteria for sarcopenia in older adults: A systematic review and meta-analysis[J]. Eur J Nutr, 2022, 61(2):637-651.
|
| [62] |
Lee SY, Lee HJ, Lim JY. Effects of leucine-rich protein supplements in older adults with sarcopenia: A systematic review and meta-analysis of randomized controlled trials[J]. Arch Gerontol Geriatr, 2022, 102:104758.
|
| [63] |
Landi F, Calvani R, Tosato M, et al. Protein intake and muscle health in old age: from biological plausibility to clinical evidence[J]. Nutrients, 2016, 8(5):295.
|
| [64] |
Hirose Y, Onishi T, Miura S, et al. Vitamin D attenuates FOXO1-target atrophy gene expression in C2C12 muscle cells[J]. J Nutr Sci Vitaminol (Tokyo), 2018, 64(3):229-232.
|
| [65] |
Teschler M, Heimer M, Schmitz B, et al. Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: A three-arm parallel randomized trial[J]. J Cachexia Sarcopenia Muscle, 2021, 12(4):843-854.
|
| [66] |
黄潇楠，方凡夫.神经肌肉电刺激对躯干稳定肌影响的研究进展[J].生物医学工程学进展，2023,44(3):244-252.
|
| [67] |
Bischoff-Ferrari HA, Orav JE, Kanis JA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older[J]. Osteoporos Int, 2015, 26(12):2793-2802.
|
| [68] |
Buckinx F, Croisier JL, Reginster JY, et al. Prediction of the incidence of falls and deaths among elderly nursing home residents: the SENIOR Study[J]. J Am Med Dir Assoc, 2018, 19(1):18-24.
|
| [69] |
Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study[J]. Clin Nutr, 2012, 31(5):652-658.
|
| [70] |
Matsumoto H, Tanimura C, Tanishima S, et al. Sarcopenia is a risk factor for falling in independently living Japanese older adults: A 2-year prospective cohort study of the GAINA study[J]. Geriatr Gerontol Int, 2017, 17(11):652-658.
|
| [71] |
Menant JC, Weber F, Lo J, et al. Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia?[J]. Osteoporos Int, 2017, 28(1):59-70.
|
| [72] |
Van Puyenbroeck K, Roelandts L, Van Deun T, et al. The additional value of bioelectrical impedance analysis-derived muscle mass as a screening tool in geriatric assessment for fall prevention[J]. Gerontology, 2012, 58(5):407-412.
|
| [73] |
Zhang HW, Cai ZR, Chen KT, et al. Enhanced risk of osteoporotic fracture in patients with sarcopenia[J]. J Pers Med, 2022, 12(5):791.
|
| [74] |
Chalhoub D, Cawthon PM, Ensrud KE, et al. Risk of nonspine fractures in older adults with sarcopenia, low bone mass, or both[J]. J Am Geriatr Soc, 2015, 63(9):1733-1740.
|
| [75] |
Harris R, Chang Y, Beavers K, et al. Risk of fracture in women with sarcopenia, low bone mass, or both[J]. J Am Geriatr Soc, 2017, 65(12):2673-2678.
|
| [76] |
Cawthon PM, Blackwell TL, Cauley J, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: Results from the observational osteoporotic fractures in men cohort study[J]. J Am Geriatr Soc, 2015, 63(11):2247-2259.
|
| [77] |
Yu R, Leung J, Woo J. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men[J]. J Am Med Dir Assoc, 2014, 15(12):918-923.
|
| [78] |
Hars M, Biver E, Chevalley T, et al. Low lean mass predicts incident fractures independently from FRAX: A prospective cohort study of recent retirees[J]. J Bone Miner Res, 2016, 31(11):2048-2056.
|
| [79] |
Scott D, Chandrasekara SD, Laslett LL, et al. Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5-10 years in community-dwelling older adults[J]. Calcif Tissue Int, 2016, 99(1):30-42.
|
| [80] |
Schaap LA, van Schoor NM, Lips P, et al. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study Amsterdam[J]. J Gerontol A Biol Sci Med Sci, 2018, 73(9): 1199-1204.
|
| [81] |
Hong W, Cheng Q, Zhu X, et al. Prevalence of sarcopenia and its relationship with sites of fragility fractures in elderly chinese men and women[J]. PLoS One, 2015, 10(9):e0138102.
|
| [82] |
穆白雪，李铭麟，王佳贺，等.老年人肌少症与跌倒风险相关性的研究进展[J].中国临床保健杂志，2022,25(5):589-592.
|
| [83] |
Shimada H, Tsutsumimoto K, Doi T, et al. Effect of sarcopenia status on disability incidence among Japanese older adults[J]. J Am Med Dir Assoc, 2021, 22(4):846-852.
|
| [84] |
Oh MH, Shin HE, Kim KS, et al. Combinations of sarcopenia diagnostic criteria by Asian Working Group of Sarcopenia (AWGS) 2019 guideline and incident adverse health outcomes in community-dwelling older adults[J]. J Am Med Dir Assoc, 2023, 24(8):1185-1192.
|
| [85] |
Bianchi L, Ferrucci L, Cherubini A, et al. The predictive value of the EWGSOP definition of sarcopenia: Results from the InCHIANTI study[J]. J Gerontol A Biol Sci Med Sci, 2016, 71(2):259-264.
|
| [86] |
Kitamura A, Seino S, Abe T, et al. Sarcopenia: Prevalence, associated factors, and the risk of mortality and disability in Japanese older adults[J]. J Cachexia Sarcopenia Muscle, 2021, 12(1):30-38.
|
| [87] |
Andrews JS, Gold LS, Reed MJ, et al. Appendicular lean mass, grip strength, and the development of hospital-associated activities of daily living disability among older adults in the health ABC study[J]. J GerontolA Biol Sci Med Sci, 2022, 77(7):1398-1404.
|
| [88] |
Cawthon PM, Blackwell T, Cummings SR, et al. Muscle mass assessed by the D3-creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community-dwelling older men[J]. J Gerontol A Biol Sci Med Sci, 2021, 76(1):123-130.
|
| [89] |
Seino S, Kitamura A, Abe T, et al. Dose-response relationships of sarcopenia parameters with incident disability and mortality in older Japanese adults[J]. J Cachexia Sarcopenia Muscle, 2022, 13(2):932-944.
|
| [90] |
Zanker J, Patel S, Blackwell T, et al. Walking speed and muscle mass estimated by the D(3)-creatine dilution method are important components of sarcopenia associated with incident mobility disability in older men: A classification and regression tree analysis[J]. J Am Med Dir Assoc, 2020, 21(12):1997-2002.
|
| [91] |
Sun T, Ma Z, Gao L, et al. Correlation between sarcopenia and arteriosclerosis in elderly community dwellers: A multicenter study[J]. J Nutr Health Aging, 2021, 25(5):692-697.
|
| [92] |
Szulc P, Chapurlat R. Rapid progression of aortic calcification in older men with low appendicular lean mass and poor physical function[J]. J Nutr Health Aging, 2021, 25(10):1217-1225.
|
| [93] |
陈长，刘辉，蔺阳刚，等.肌少症在老年动脉粥样硬化性心血管疾病发病中的作用研究进展[J].解放军医学杂志，2021,46(5):512-517.
|
| [94] |
Gao K, Cao LF, Ma WZ, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study[J]. EClinical Medicine, 2022, 44: 101264.
|
| [95] |
Fukuda T, Bouchi R, Takeuchi T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: A retrospective observational study[J]. Cardiovasc Diabetol, 2018, 17(1):55.
|
| [96] |
兰琴，田茂露，袁静，等.正常体质指数血液透析患者腰围身高比与肌少症性肥胖的相关性[J].中华医学杂志，2024,104(12):931-937.
|